123 related articles for article (PubMed ID: 6629140)
1. Estrogen - and gestagen - receptors in ovarian carcinoma.
Spona J; Gitsch E; Salzer H; Karrer K
Gynecol Obstet Invest; 1983; 16(4):189-98. PubMed ID: 6629140
[TBL] [Abstract][Full Text] [Related]
2. Enzyme immunoassay and Scatchard plot estimation of estrogen receptor in gynecological tumors.
Spona J; Gitsch E; Kubista E; Salzer H; Köhler B
Cancer Res; 1986 Aug; 46(8 Suppl):4310s-4312s. PubMed ID: 2425949
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.
Sevelda P; Denison U; Schemper M; Spona J; Vavra N; Salzer H
Br J Obstet Gynaecol; 1990 Aug; 97(8):706-12. PubMed ID: 2400748
[TBL] [Abstract][Full Text] [Related]
4. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
Spona J; Ulm R; Bieglmayer C; Husslein P
Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
Layfield LJ; Saria EA; Conlon DH; Kerns BJ
J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
[TBL] [Abstract][Full Text] [Related]
7. The nontransformed progesterone and estrogen receptors in gastric cancer.
Wu CW; Chang HM; Kao HL; Lui WY; P'eng FK; Chi CW
Gastroenterology; 1992 May; 102(5):1639-46. PubMed ID: 1373695
[TBL] [Abstract][Full Text] [Related]
8. Correlation between steroid hormone receptors, histological and clinical parameters in ovarian carcinoma.
Anderl P; Fuith LC; Daxenbichler G; Marth C; Dapunt O
Gynecol Obstet Invest; 1988; 25(2):135-40. PubMed ID: 3371761
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
10. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
11. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
[TBL] [Abstract][Full Text] [Related]
13. Relationship between low estrogen receptor values and other prognostic factors in primary breast tumors.
Gaffney EV; Halpin DP; Blakemore WS
Surgery; 1995 Mar; 117(3):241-6. PubMed ID: 7878527
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptors in epithelial ovarian malignancies.
Sutton GP; Senior MB; Strauss JF; Mikuta JJ
Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
[TBL] [Abstract][Full Text] [Related]
16. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
Teufel G; Geyer H; de Gregorio G; Fuchs A; Kleine W; Pfleiderer A
Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):732-40. PubMed ID: 6559148
[TBL] [Abstract][Full Text] [Related]
17. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation.
Bozzetti C; Camisa R; Nizzoli R; Manotti L; Guazzi A; Naldi N; Mazza S; Nizzoli V; Cocconi G
Surg Neurol; 1995 Mar; 43(3):230-3; discussion 234. PubMed ID: 7792684
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors.
Nagasue N; Kohno H; Yamanoi A; Kimoto T; Chang YC; Nakamura T
Cancer; 1991 May; 67(10):2501-5. PubMed ID: 1849788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
